After Treatment with Sterionics' Device
The study of Sterionics technology at the Calhoun Lab at Akron General is the first joint project between the Akron General Medical
and 5iTech, LLC
, one of Sterionics’ founders. The work has centered on wound care and infection prevention, and will continue
to focus on the validation of a micro “cold plasma” device that has demonstrated strong antibacterial, antiviral and antifungal properties
in a wide variety of medical and dental applications.
“We are pleased to collaborate with 5iTech to further develop this innovative technology to improve patient care associated with the
management of simple and complex infections,” said James Dougherty, MD, Chairman of Medical Education and Research at Akron General
Sterionics plans validation studies of its technology and prepares for collaboration with at Akron General Medical Center.
Akron General’s Technology Transfer, Commercialization and Innovation Office brings life-improving ideas to the patient’s bedside.
The office serves as a gateway for enterprising companies to access medical intellectual expertise and consultation for potential
Sterionics Collaborates with Akron General Medical Center.
Sterionics wins Great Lakes Innovation and Development Enterprise (GLIDE) Grant.